332 related articles for article (PubMed ID: 28262603)
1. Biological profiling of prospective antidepressant response in major depressive disorder: Associations with (neuro)inflammation, fatty acid metabolism, and amygdala-reactivity.
Mocking RJT; Nap TS; Westerink AM; Assies J; Vaz FM; Koeter MWJ; Ruhé HG; Schene AH
Psychoneuroendocrinology; 2017 May; 79():84-92. PubMed ID: 28262603
[TBL] [Abstract][Full Text] [Related]
2. Fatty acid metabolism and its longitudinal relationship with the hypothalamic-pituitary-adrenal axis in major depression: Associations with prospective antidepressant response.
Mocking RJ; Verburg HF; Westerink AM; Assies J; Vaz FM; Koeter MW; Ruhé HG; Schene AH
Psychoneuroendocrinology; 2015 Sep; 59():1-13. PubMed ID: 26010860
[TBL] [Abstract][Full Text] [Related]
3. Amygdala Reactivity to Emotional Faces in the Prediction of General and Medication-Specific Responses to Antidepressant Treatment in the Randomized iSPOT-D Trial.
Williams LM; Korgaonkar MS; Song YC; Paton R; Eagles S; Goldstein-Piekarski A; Grieve SM; Harris AW; Usherwood T; Etkin A
Neuropsychopharmacology; 2015 Sep; 40(10):2398-408. PubMed ID: 25824424
[TBL] [Abstract][Full Text] [Related]
4. Baseline serum C-reactive protein levels may predict antidepressant treatment responses in patients with major depressive disorder.
Zhang J; Yue Y; Thapa A; Fang J; Zhao S; Shi W; Yang Z; Li Y; Yuan Y
J Affect Disord; 2019 May; 250():432-438. PubMed ID: 30878656
[TBL] [Abstract][Full Text] [Related]
5. Functional connectivity of the amygdala subregions and the antidepressant effects of repeated ketamine infusions in major depressive disorder.
Liu H; Wang C; Lan X; Li W; Zhang F; Hu Z; Ye Y; Ning Y; Zhou Y
Eur Psychiatry; 2024 Apr; 67(1):e33. PubMed ID: 38572583
[TBL] [Abstract][Full Text] [Related]
6. Hippocampal volume predicts antidepressant efficacy in depressed patients without incomplete hippocampal inversion.
Colle R; Cury C; Chupin M; Deflesselle E; Hardy P; Nasser G; Falissard B; Ducreux D; Colliot O; Corruble E
Neuroimage Clin; 2016; 12():949-955. PubMed ID: 27995060
[TBL] [Abstract][Full Text] [Related]
7. Successful pharmacologic treatment of major depressive disorder attenuates amygdala activation to negative facial expressions: a functional magnetic resonance imaging study.
Ruhé HG; Booij J; Veltman DJ; Michel MC; Schene AH
J Clin Psychiatry; 2012 Apr; 73(4):451-9. PubMed ID: 21903032
[TBL] [Abstract][Full Text] [Related]
8. Occupancy of serotonin transporters in the amygdala by paroxetine in association with attenuation of left amygdala activation by negative faces in major depressive disorder.
Ruhé HG; Koster M; Booij J; van Herk M; Veltman DJ; Schene AH
Psychiatry Res; 2014 Feb; 221(2):155-61. PubMed ID: 24406081
[TBL] [Abstract][Full Text] [Related]
9. Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism.
Drevets WC; Bogers W; Raichle ME
Eur Neuropsychopharmacol; 2002 Dec; 12(6):527-44. PubMed ID: 12468016
[TBL] [Abstract][Full Text] [Related]
10. Effect of agomelatine treatment on C-reactive protein levels in patients with major depressive disorder: an exploratory study in "real-world," everyday clinical practice.
De Berardis D; Fornaro M; Orsolini L; Iasevoli F; Tomasetti C; de Bartolomeis A; Serroni N; De Lauretis I; Girinelli G; Mazza M; Valchera A; Carano A; Vellante F; Matarazzo I; Perna G; Martinotti G; Di Giannantonio M
CNS Spectr; 2017 Aug; 22(4):342-347. PubMed ID: 27702411
[TBL] [Abstract][Full Text] [Related]
11. Decreased Pretreatment Amygdalae Serotonin Transporter Binding in Unipolar Depression Remitters: A Prospective PET Study.
Ananth MR; DeLorenzo C; Yang J; Mann JJ; Parsey RV
J Nucl Med; 2018 Apr; 59(4):665-670. PubMed ID: 28935838
[TBL] [Abstract][Full Text] [Related]
12. Decreased sensitivity to paroxetine-induced inhibition of peripheral blood mononuclear cell growth in depressed and antidepressant treatment-resistant patients.
Rzezniczek S; Obuchowicz M; Datka W; Siwek M; Dudek D; Kmiotek K; Oved K; Shomron N; Gurwitz D; Pilc A
Transl Psychiatry; 2016 May; 6(5):e827. PubMed ID: 27244236
[TBL] [Abstract][Full Text] [Related]
13. Incapacity to control emotion in major depression may arise from disrupted white matter integrity and OFC-amygdala inhibition.
Zheng KZ; Wang HN; Liu J; Xi YB; Li L; Zhang X; Li JM; Yin H; Tan QR; Lu HB; Li BJ
CNS Neurosci Ther; 2018 Nov; 24(11):1053-1062. PubMed ID: 29368421
[TBL] [Abstract][Full Text] [Related]
14. Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder.
Meier TB; Drevets WC; Wurfel BE; Ford BN; Morris HM; Victor TA; Bodurka J; Teague TK; Dantzer R; Savitz J
Brain Behav Immun; 2016 Mar; 53():39-48. PubMed ID: 26546831
[TBL] [Abstract][Full Text] [Related]
15. Treatment response and cognitive impairment in major depression: association with C-reactive protein.
Chang HH; Lee IH; Gean PW; Lee SY; Chi MH; Yang YK; Lu RB; Chen PS
Brain Behav Immun; 2012 Jan; 26(1):90-5. PubMed ID: 21839826
[TBL] [Abstract][Full Text] [Related]
16. Sex differences in the association of baseline c-reactive protein (CRP) and acute-phase treatment outcomes in major depressive disorder: Findings from the EMBARC study.
Jha MK; Minhajuddin A; Chin-Fatt C; Greer TL; Carmody TJ; Trivedi MH
J Psychiatr Res; 2019 Jun; 113():165-171. PubMed ID: 30959227
[TBL] [Abstract][Full Text] [Related]
17. An investigation of cortical thickness and antidepressant response in major depressive disorder: A CAN-BIND study report.
Suh JS; Minuzzi L; Raamana PR; Davis A; Hall GB; Harris J; Hassel S; Zamyadi M; Arnott SR; Alders GL; Sassi RB; Milev R; Lam RW; MacQueen GM; Strother SC; Kennedy SH; Frey BN
Neuroimage Clin; 2020; 25():102178. PubMed ID: 32036277
[TBL] [Abstract][Full Text] [Related]
18. Vulnerability for new episodes in recurrent major depressive disorder: protocol for the longitudinal DELTA-neuroimaging cohort study.
Mocking RJ; Figueroa CA; Rive MM; Geugies H; Servaas MN; Assies J; Koeter MW; Vaz FM; Wichers M; van Straalen JP; de Raedt R; Bockting CL; Harmer CJ; Schene AH; Ruhé HG
BMJ Open; 2016 Mar; 6(3):e009510. PubMed ID: 26932139
[TBL] [Abstract][Full Text] [Related]
19. Omega-3 fatty acids for inflamed depression - A match/mismatch study.
Suneson K; Söderberg Veibäck G; Lindahl J; Tjernberg J; Ståhl D; Ventorp S; Ängeby F; Lundblad K; Wolkowitz OM; Lindqvist D
Brain Behav Immun; 2024 May; 118():192-201. PubMed ID: 38432599
[TBL] [Abstract][Full Text] [Related]
20. Increased temporal variability of striatum region facilitating the early antidepressant response in patients with major depressive disorder.
Hou Z; Kong Y; He X; Yin Y; Zhang Y; Yuan Y
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jul; 85():39-45. PubMed ID: 29608926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
